Search result

Phantom 4 RTK/feed/category/dji-matrice-30t-pl- Page 56

Procter & Gamble (PG) News Today: CEO Transition Nears, Prague “Artemis” Expansion, and Wall Street Forecasts (Dec. 25, 2025)

Procter & Gamble (PG) News Today: CEO Transition Nears, Prague “Artemis” Expansion, and Wall Street Forecasts (Dec. 25, 2025)

Procter & Gamble will appoint Shailesh Jejurikar as CEO on January 1, 2026, with Jon Moeller moving to executive chairman. Swedbank AB increased its stake in the company, while Rep. Ed Case disclosed a small stock sale. Analysts adjusted price targets after a recent pullback. P&G is also advancing a new logistics and production hub near Prague.
25 december 2025
Unilever PLC Stock (UL, ULVR) Outlook on Dec. 26, 2025: Magnum Spin-Off Aftermath, Analyst Targets, and What Comes Next

Unilever PLC Stock (UL, ULVR) Outlook on Dec. 26, 2025: Magnum Spin-Off Aftermath, Analyst Targets, and What Comes Next

Unilever completed the demerger of its ice cream business in December, spinning off The Magnum Ice Cream Company and consolidating shares to adjust per-share metrics. UK markets closed on December 26, leaving Unilever’s London price unchanged at 4,838.00p with zero volume; the US ADR last closed at $65.99 on December 24. Magnum debuted at €12.80 per share, with Unilever retaining a 19.9% stake.
Target Stock (TGT) Rises on Activist Stake Report as Wall Street Trades Near Record Highs: Latest News, Analyst Forecasts, and What Investors Are Watching

Target Stock (TGT) Rises on Activist Stake Report as Wall Street Trades Near Record Highs: Latest News, Analyst Forecasts, and What Investors Are Watching

Target shares rose 2.3% to $98.77 Friday after reports that Toms Capital Investment Management took a significant stake in the retailer. The move follows a year in which Target stock fell 26% amid weak sales and heavy competition. The activist investment comes ahead of a CEO transition set for February 1, 2026. TCIM has not commented on the size of its position.
26 december 2025
Eli Lilly Stock (LLY) Today: GLP‑1 Price Cuts, the Obesity Pill Race, and What Investors Are Watching Into 2026

Eli Lilly Stock (LLY) Today: GLP‑1 Price Cuts, the Obesity Pill Race, and What Investors Are Watching Into 2026

Eli Lilly shares traded near $1,075 Friday afternoon, down 0.2% in thin post-Christmas trading as U.S. indexes hovered close to record highs. The stock moved between $1,068 and $1,082 amid muted volume. The NYSE and Nasdaq remained open for a regular session. Investors continue to watch Lilly’s pricing moves and its lead in obesity and diabetes treatments.
Home Depot Stock (HD) Update: Year-End Trading, 2026 Outlook, and What Investors Should Watch Before Monday’s Open

Home Depot Stock (HD) Update: Year-End Trading, 2026 Outlook, and What Investors Should Watch Before Monday’s Open

Home Depot shares closed at $349.78 Friday as U.S. stock markets ended a quiet post-Christmas session with major indexes slightly lower. The company’s 2026 outlook, released December 9, forecasts flat to modest growth in comparable sales and earnings, falling short of Wall Street expectations. Management cited continued weakness in the home improvement market. Markets reopen Monday, December 29.
27 december 2025
Altria Group Stock (MO) Slides After Ex-Dividend Session as Investors Track NJOY Legal Fight and FDA Green Light for on! PLUS Nicotine Pouches

Altria Group Stock (MO) Slides After Ex-Dividend Session as Investors Track NJOY Legal Fight and FDA Green Light for on! PLUS Nicotine Pouches

Altria shares fell 2.34% to $57.60 Friday as the stock traded ex-dividend, with the $1.06 per share payout set for Jan. 9. Juul Labs asked an Arizona judge to block Altria and NJOY from using documents uploaded to a UCSF database, arguing the records could affect a vape patent dispute. The broader market saw light trading and finished slightly lower.
27 december 2025
AbbVie Stock (ABBV) Holds Near $230 as Year-End “Santa Rally” Takes Shape; Dividend Boost, Legal Headlines and 2026 Outlook in Focus

AbbVie Stock (ABBV) Holds Near $230 as Year-End “Santa Rally” Takes Shape; Dividend Boost, Legal Headlines and 2026 Outlook in Focus

AbbVie closed Friday at $229.98, near its 52-week high, as U.S. markets ended a quiet post-holiday session with major indexes little changed. No major AbbVie corporate news broke in the past two days, but investor analysis and institutional filings kept the stock in focus. Institutions and hedge funds hold about 70% of shares. The next regular trading session is Monday.
Warby Parker Stock (NYSE: WRBY) Ends Week Lower: Friday’s 8% Slide, Analyst Price Targets, and What to Watch Before Monday’s Open

Warby Parker Stock (NYSE: WRBY) Ends Week Lower: Friday’s 8% Slide, Analyst Price Targets, and What to Watch Before Monday’s Open

Warby Parker shares fell 8.2% to $24.18 Friday, closing near session lows after a volatile day and standing out in otherwise quiet post-holiday trading. No new company news was released, but the stock’s recent swings follow December headlines about its $150 million “intelligent eyewear” partnership with Google. Trading volume reached about 3.88 million shares. U.S. markets reopen Monday.
28 december 2025
Eli Lilly Stock (LLY) News Today: What Investors Should Watch Before Monday’s Open After GLP‑1 Pill Breakthroughs, Pricing Signals, and Fresh Deal Headlines

Eli Lilly Stock (LLY) News Today: What Investors Should Watch Before Monday’s Open After GLP‑1 Pill Breakthroughs, Pricing Signals, and Fresh Deal Headlines

Eli Lilly shares closed at $1,077.75 Friday, near record highs, as U.S. markets shut for the weekend. ABL Bio announced $55 million in new funding tied to Lilly, including a $40 million upfront payment and $15 million equity investment. Investors remain focused on obesity-drug momentum and the FDA’s recent approval of Novo Nordisk’s weight-loss pill.
28 december 2025
Hims & Hers stock dips in premarket as GLP-1 drug pricing pressure stays in focus

Hims & Hers stock dips in premarket as GLP-1 drug pricing pressure stays in focus

Hims & Hers Health shares fell 0.5% to $32.87 in premarket trading Wednesday after closing down 3.1% the previous session. The move follows price cuts by Novo Nordisk and Eli Lilly on obesity drugs in China, raising questions about future margins and demand for GLP-1 therapies. Hims recently launched its weight-loss membership in the UK, offering access to Wegovy and Mounjaro.
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

Stock Market Today 27.01.2026

5N Plus Inc. shares have surged over 1,200% in a decade, while Brookfield Infrastructure Partners trades near $48.35, up from $20 ten years ago. PROCEPT BioRobotics rose 3.95% in one day but remains down 57.81% year-over-year. Micron Technology posted 57% cloud revenue growth and trades at a forward P/E of 11.6. India’s Sensex jumped nearly 600 points to 82,451 on trade deal optimism.
27 januari 2026
Colgate-Palmolive stock price jumps 6% after earnings; what CL investors watch next week

Colgate-Palmolive stock price jumps 6% after earnings; what CL investors watch next week

Colgate-Palmolive shares rose 6% to $90.29 Friday after fourth-quarter net sales climbed 5.8% to $5.23 billion, but GAAP earnings swung to a loss due to a $794 million skin-health impairment. The company’s 2026 outlook includes finalized tariffs and projects net sales growth of 2% to 6%. North America sales fell, while Latin America and Africa/Eurasia posted double-digit gains.
Quhuo Limited (NASDAQ: QH) Soars on Heavy Volume Today, Nov 12, 2025 — No New Filings, Recent Catalysts in Focus

Quhuo Limited (NASDAQ: QH) Soars on Heavy Volume Today, Nov 12, 2025 — No New Filings, Recent Catalysts in Focus

Quhuo Limited’s shares (NASDAQ: QH) jumped over 56% to about $1.30 by midday Wednesday, with trading volume nearing 47 million, according to StockAnalysis. No new press releases or SEC filings appeared today. MarketScreener tracked QH up 71% earlier in the session. Recent catalysts include an August reverse split and a $50 million at-the-market program.
12 november 2025
Gambling.com Group (GAMB) Stock Crashes After Record Q3 2025 Earnings and Guidance Cut

Gambling.com Group (GAMB) Stock Crashes After Record Q3 2025 Earnings and Guidance Cut

Gambling.com Group shares fell over 25% Thursday after reporting record Q3 2025 revenue of $38.98 million, up 21% year-over-year, but posting a net loss of $3.86 million versus a profit last year. The company cited search-traffic headwinds and a cautious outlook. By mid-morning, the stock traded near $5.08, down more than 70% from its 52-week high. Sports data services revenue surged 304% to $9.2 million.
IREN Stock Falls on November 13 as Market Questions Earnings Quality After Record Q1 and $9.7B Microsoft AI Cloud Deal

IREN-Aktie fällt am 13. November, da der Markt nach Rekord-Q1 und 9,7-Milliarden-Dollar-Microsoft-AI-Cloud-Deal die Ergebnisqualität hinterfragt

Die Aktie von IREN Limited fiel am Donnerstagvormittag um rund 9 % auf etwa $50,73, nachdem ein Artikel Zweifel an der Qualität der jüngsten Gewinne geäußert hatte. Das Papier eröffnete bei $52,75 nach einem Vortagesschluss von $55,70. CEO Daniel Roberts verkaufte zuletzt Aktien. Der Kursrückgang folgt auf einen milliardenschweren KI-Cloud-Deal mit Microsoft.
14 november 2025
Stimulus Check October 2025: Rumors Debunked – What to Know as Shutdown Continues

IRS Direct Deposit & 2025 Stimulus Checks: November Relief Payment Rumors, Tariff Dividend and DOGE Checks Explained (November 14, 2025)

No new IRS stimulus checks or direct deposit relief payments are scheduled or approved for November 2025, according to the IRS. Viral claims of $1,390 or $2,000 payments, and so-called “DOGE checks,” are false or unverified. Congress has not passed new stimulus legislation. The IRS warns that messages asking for personal details to “pre-register” are scams.
14 november 2025
MDA Space Stock Plunges Over 50% on SpaceX Shock, But Q3 2025 Earnings and Wireless Power Deal Rekindle Bull Hopes

MDA Space Stock Plunges Over 50% on SpaceX Shock, But Q3 2025 Earnings and Wireless Power Deal Rekindle Bull Hopes

MDA Space shares have dropped over 55% from their 52-week high after EchoStar canceled a $1.3 billion satellite contract and sold spectrum to SpaceX. The company reported strong Q3 2025 results and reaffirmed guidance on November 14, but market focus remains on lost backlog and customer shifts toward SpaceX.
1 54 55 56 57 58 172
Go toTop